ReP USP - Resultado da busca

Artigo de periodico
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents (2024)
Waitman, Karoline de Barros ; Almeida, Larissa Costa de ; Primi, Marina Candido ; Carlos, Jorge Antonio Elias Godoy ; Ruiz, Claudia; Kronenberger, Thales ; Laufer, Stefan; Goettert, Marcia Ines; Poso, Antti ; Vassiliades, Sandra Valeria ; Souza, Vinicius Albuquerque Moreira de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Cameron, Michael D; Bannister, Thomas D; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho ; Tavares, Maurício T.; Parise Filho, Roberto
Fonte: European Journal of Medicinal Chemistry. Unidades: FCF, ICB
Assuntos: ANTINEOPLÁSICOS, HIBRIDIZAÇÃO, CÉLULAS CULTIVADAS DE TUMOR, PROTEÍNAS, PURINAS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, v. 263, p. 1-18 art. 115935, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ejmech.2023.115935. Acesso em: 24 jun. 2024.
APA
Waitman, K. de B., Almeida, L. C. de, Primi, M. C., Carlos, J. A. E. G., Ruiz, C., Kronenberger, T., et al. (2024). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, 263, 1-18 art. 115935. doi:10.1016/j.ejmech.2023.115935
NLM
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Lotufo LVC, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 jun. 24 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Vancouver
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Lotufo LVC, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 jun. 24 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Artigo de periodico
Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites (2024)
Crispim, Marcell ; Verdaguer, Ignasi Bofill ; Hernández, Agustín ; Kronenberger, Thales ; Fenollar, Àngel ; Yamaguchi, Lydia Fumiko ; Alberione, María Pía ; Ramirez, Miriam; Oliveira, Sandra Souza de; Izquierdo, Luis ; Katzin, Alejandro Miguel
Fonte: PLoS Pathogens. Unidades: FCF, ICB
Assuntos: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, METABÓLITOS, PROTEÍNAS QUINASES, ANIMAIS PARASITOS, PLASMODIUM FALCIPARUM, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRISPIM, Marcell et al. Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites. PLoS Pathogens, v. 20, n. 1, p. 29 , 2024Tradução . . Disponível em: https://doi.org/10.1371/journal.ppat.1011557. Acesso em: 24 jun. 2024.
APA
Crispim, M., Verdaguer, I. B., Hernández, A., Kronenberger, T., Fenollar, À., Yamaguchi, L. F., et al. (2024). Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites. PLoS Pathogens, 20( 1), 29 . doi:10.1371/journal.ppat.1011557
NLM
Crispim M, Verdaguer IB, Hernández A, Kronenberger T, Fenollar À, Yamaguchi LF, Alberione MP, Ramirez M, Oliveira SS de, Izquierdo L, Katzin AM. Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites [Internet]. PLoS Pathogens. 2024 ; 20( 1): 29 .[citado 2024 jun. 24 ] Available from: https://doi.org/10.1371/journal.ppat.1011557
Vancouver
Crispim M, Verdaguer IB, Hernández A, Kronenberger T, Fenollar À, Yamaguchi LF, Alberione MP, Ramirez M, Oliveira SS de, Izquierdo L, Katzin AM. Beyond the MEP pathway: A novel kinase required for prenol utilization by malaria parasites [Internet]. PLoS Pathogens. 2024 ; 20( 1): 29 .[citado 2024 jun. 24 ] Available from: https://doi.org/10.1371/journal.ppat.1011557
Artigo de periodico
MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling (2023)
Veríssimo, Gabriel Corrêa ; Simone Queiroz Panteleão; Gertrudes, Jadson Castro ; Kronenberger, Thales ; Honorio, Kathia Maria ; Maltarollo, Vinícius Gonçalves
Fonte: Journal of Computer - Aided Molecular Design. Unidade: EACH
Assunto: AMOSTRAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERÍSSIMO, Gabriel Corrêa et al. MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling. Journal of Computer - Aided Molecular Design, p. 01-26, 2023Tradução . . Disponível em: http://dx.doi.org/10.1007/s10822-023-00536-y. Acesso em: 24 jun. 2024.
APA
Veríssimo, G. C., Simone Queiroz Panteleão,, Gertrudes, J. C., Kronenberger, T., Honorio, K. M., & Maltarollo, V. G. (2023). MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling. Journal of Computer - Aided Molecular Design, 01-26. doi:10.1007/s10822-023-00536-y
NLM
Veríssimo GC, Simone Queiroz Panteleão, Gertrudes JC, Kronenberger T, Honorio KM, Maltarollo VG. MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling [Internet]. Journal of Computer - Aided Molecular Design. 2023 ; 01-26.[citado 2024 jun. 24 ] Available from: http://dx.doi.org/10.1007/s10822-023-00536-y
Vancouver
Veríssimo GC, Simone Queiroz Panteleão, Gertrudes JC, Kronenberger T, Honorio KM, Maltarollo VG. MASSA Algorithm: automated rational sampling of training and test subsets for QSAR modelling [Internet]. Journal of Computer - Aided Molecular Design. 2023 ; 01-26.[citado 2024 jun. 24 ] Available from: http://dx.doi.org/10.1007/s10822-023-00536-y
Artigo de periodico
Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells (2023)
Los, Bruna ; Ferreira, Glaucio Monteiro ; Borges, Jéssica Bassani ; Kronenberger, Thales ; Oliveira, Victor Fernandes de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad; Mori, Augusto Akira ; Barbosa, Thais Kristini Almendros; Freitas, Renata Caroline Costa de ; Jannes, Cinthia Elim ; Pereira, Alexandre da Costa; Bastos, Gisele Medeiros ; Poso, Antti ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Gene. Unidades: FM, FCF
Assuntos: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells. Gene, v. 851, p. 1-14 art. 146979, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2022.146979. Acesso em: 24 jun. 2024.
APA
Los, B., Ferreira, G. M., Borges, J. B., Kronenberger, T., Oliveira, V. F. de, Hernandez, C. D., et al. (2023). Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells. Gene, 851, 1-14 art. 146979. doi:10.1016/j.gene.2022.146979
NLM
Los B, Ferreira GM, Borges JB, Kronenberger T, Oliveira VF de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Mori AA, Barbosa TKA, Freitas RCC de, Jannes CE, Pereira A da C, Bastos GM, Poso A, Hirata RDC, Hirata MH. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells [Internet]. Gene. 2023 ; 851 1-14 art. 146979.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.gene.2022.146979
Vancouver
Los B, Ferreira GM, Borges JB, Kronenberger T, Oliveira VF de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Mori AA, Barbosa TKA, Freitas RCC de, Jannes CE, Pereira A da C, Bastos GM, Poso A, Hirata RDC, Hirata MH. Effects of PCSK9 missense variants on molecular conformation and biological activity in transfected HEK293FT cells [Internet]. Gene. 2023 ; 851 1-14 art. 146979.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.gene.2022.146979
Artigo de periodico
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors (2023)
Tavares, Maurício Temotheo ; Krüger, Arne ; Yan, Sun Liu Rei ; Waitman, Karoline de Barros ; Gomes, Vinícius de Morais ; Oliveira, Daffiny Sumam de ; Paz, Franciarli ; Hilscher, Sebastian ; Schutkowski, Mike ; Sippl, Wolfgang ; Ruiz, Claudia; Toledo, Mônica Franco Zannini Junqueira ; Poso, Antti ; Cameron, Michael D. ; Bannister, Thomas D. ; Kronenberger, Thales ; Parise Filho, Roberto ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Palmisano, Giuseppe ; Wrenger, Carsten
Fonte: Scientific Reports. Unidades: FCF, ICB
Assuntos: FARMACOLOGIA, PARASITOLOGIA, ANTIMALÁRICOS, EPIGÊNESE GENÉTICA, ÁCIDO FÓLICO, ANTAGONISTAS, PROTEÍNAS, PROTEÍNAS RECOMBINANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, v. 13, n. 1, p. 20 , 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-47959-z. Acesso em: 24 jun. 2024.
APA
Tavares, M. T., Krüger, A., Yan, S. L. R., Waitman, K. de B., Gomes, V. de M., Oliveira, D. S. de, et al. (2023). 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors. Scientific Reports, 13( 1), 20 . doi:10.1038/s41598-023-47959-z
NLM
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 jun. 24 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Vancouver
Tavares MT, Krüger A, Yan SLR, Waitman K de B, Gomes V de M, Oliveira DS de, Paz F, Hilscher S, Schutkowski M, Sippl W, Ruiz C, Toledo MFZJ, Poso A, Cameron MD, Bannister TD, Kronenberger T, Parise Filho R, Hassimotto NMA, Machado Neto JA, Palmisano G, Wrenger C. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors [Internet]. Scientific Reports. 2023 ; 13( 1): 20 .[citado 2024 jun. 24 ] Available from: https://doi.org/10.1038/s41598-023-47959-z
Trabalho de evento-resumo
Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment (2023)
Waitman, Karoline de Barros ; Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Carlos, Jorge Antonio Elias Godoy ; Kronenberger, Thales ; Toledo, Mônica Franco Zannini Junqueira ; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho ; Parise Filho, Roberto
Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química/RASBQ. Unidades: FCF, ICB
Assuntos: NEOPLASIAS, HIBRIDIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. 2023, Anais.. São Paulo: Sociedade Brasileira de Química/SBQ, 2023. Disponível em: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf. Acesso em: 24 jun. 2024.
APA
Waitman, K. de B., Tavares, M. T., Almeida, L. C. de, Carlos, J. A. E. G., Kronenberger, T., Toledo, M. F. Z. J., et al. (2023). Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment. In Anais. São Paulo: Sociedade Brasileira de Química/SBQ. Recuperado de https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
NLM
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Lotufo LVC, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 jun. 24 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Vancouver
Waitman K de B, Tavares MT, Almeida LC de, Carlos JAEG, Kronenberger T, Toledo MFZJ, Lotufo LVC, Machado Neto JA, Parise Filho R. Design and synthesis of new potential PI3K and HDAC6 hybrid inhibitors for cancer treatment [Internet]. Anais. 2023 ;[citado 2024 jun. 24 ] Available from: https://www.sbq.org.br/46ra/anexos/anais-46rasbq.pdf
Artigo de periodico
Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design (2023)
Ferreira, Glaucio Monteiro ; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Poso, Antti ; Gatti, Fernando de Moura ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Lopes, Carla Duque ; Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Fonte: Pharmaceuticals. Unidades: FCF, IQ, FCFRP
Assuntos: TRYPANOSOMA CRUZI, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 24 jun. 2024.
APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428
NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 jun. 24 ] Available from: https://doi.org/10.3390/ph16030428
Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 jun. 24 ] Available from: https://doi.org/10.3390/ph16030428
Artigo de periodico
Inhibitor induced conformational changes in SARS-COV-2 papain-like protease (2022)
Ferreira, Glaucio Monteiro ; Pillaiyar, Thanigaimalai ; Hirata, Mario Hiroyuki ; Poso, Antti ; Kronenberger, Thales
Fonte: Scientifc Reports. Unidade: FCF
Assuntos: COVID-19, LIGANTES, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Scientifc Reports, v. 12, p. 1-13 art. 11585, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-15181-y. Acesso em: 24 jun. 2024.
APA
Ferreira, G. M., Pillaiyar, T., Hirata, M. H., Poso, A., & Kronenberger, T. (2022). Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Scientifc Reports, 12, 1-13 art. 11585. doi:10.1038/s41598-022-15181-y
NLM
Ferreira GM, Pillaiyar T, Hirata MH, Poso A, Kronenberger T. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease [Internet]. Scientifc Reports. 2022 ; 12 1-13 art. 11585.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1038/s41598-022-15181-y
Vancouver
Ferreira GM, Pillaiyar T, Hirata MH, Poso A, Kronenberger T. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease [Internet]. Scientifc Reports. 2022 ; 12 1-13 art. 11585.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1038/s41598-022-15181-y
Artigo de periodico
Glycoprotein molecular dynamics analysis (2022)
Coutinho, João Victor Paccini ; Silva, Janaina Macedo da ; Mule, Simon Ngao ; Kronenberger, Thales ; Fernandes, Livia Rosa ; Wrenger, Carsten ; Palmisano, Giuseppe
Fonte: Advances in Protein Chemistry and Structural Biology. Unidade: ICB
Assuntos: PARASITOLOGIA, GLICOPROTEÍNAS, POLISSACARÍDEOS, GLICOSAMINOGLICANAS, METABOLISMO DE PROTEÍNA, ATIVAÇÃO ENZIMÁTICA, SIMULAÇÃO DE SISTEMAS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COUTINHO, João Victor Paccini et al. Glycoprotein molecular dynamics analysis. Advances in Protein Chemistry and Structural Biology, v. 131, p. 277-3091, 2022Tradução . . Disponível em: https://doi.org/10.1016/bs.apcsb.2022.05.004. Acesso em: 24 jun. 2024.
APA
Coutinho, J. V. P., Silva, J. M. da, Mule, S. N., Kronenberger, T., Fernandes, L. R., Wrenger, C., & Palmisano, G. (2022). Glycoprotein molecular dynamics analysis. Advances in Protein Chemistry and Structural Biology, 131, 277-3091. doi:10.1016/bs.apcsb.2022.05.004
NLM
Coutinho JVP, Silva JM da, Mule SN, Kronenberger T, Fernandes LR, Wrenger C, Palmisano G. Glycoprotein molecular dynamics analysis [Internet]. Advances in Protein Chemistry and Structural Biology. 2022 ; 131 277-3091.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/bs.apcsb.2022.05.004
Vancouver
Coutinho JVP, Silva JM da, Mule SN, Kronenberger T, Fernandes LR, Wrenger C, Palmisano G. Glycoprotein molecular dynamics analysis [Internet]. Advances in Protein Chemistry and Structural Biology. 2022 ; 131 277-3091.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/bs.apcsb.2022.05.004
Artigo de periodico
SARS-COV-2 M pro conformational changes induced by covalently bound ligands (2022)
Ferreira, Glaucio Monteiro ; Kronenberger, Thales ; Tonduru, Arun Kumar; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Poso, Antti
Fonte: Journal of Biomolecular Structure and Dynamics. Unidade: FCF
Assuntos: COVID-19, LIGANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. SARS-COV-2 M pro conformational changes induced by covalently bound ligands. Journal of Biomolecular Structure and Dynamics, v. 40, n. 22, 2022Tradução . . Disponível em: https://doi.org/10.1080/07391102.2021.1970626. Acesso em: 24 jun. 2024.
APA
Ferreira, G. M., Kronenberger, T., Tonduru, A. K., Hirata, R. D. C., Hirata, M. H., & Poso, A. (2022). SARS-COV-2 M pro conformational changes induced by covalently bound ligands. Journal of Biomolecular Structure and Dynamics, 40( 22). doi:10.1080/07391102.2021.1970626
NLM
Ferreira GM, Kronenberger T, Tonduru AK, Hirata RDC, Hirata MH, Poso A. SARS-COV-2 M pro conformational changes induced by covalently bound ligands [Internet]. Journal of Biomolecular Structure and Dynamics. 2022 ; 40( 22):[citado 2024 jun. 24 ] Available from: https://doi.org/10.1080/07391102.2021.1970626
Vancouver
Ferreira GM, Kronenberger T, Tonduru AK, Hirata RDC, Hirata MH, Poso A. SARS-COV-2 M pro conformational changes induced by covalently bound ligands [Internet]. Journal of Biomolecular Structure and Dynamics. 2022 ; 40( 22):[citado 2024 jun. 24 ] Available from: https://doi.org/10.1080/07391102.2021.1970626
Artigo de periodico
Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors (2021)
Tavares, Maurício Temotheo ; Almeida, Larissa Costa de ; Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Divitiis, Thainá Fujii de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Machado Neto, João Agostinho ; Lotufo, Leticia Veras Costa ; Parise Filho, Roberto
Fonte: Bioorganic and Medicinal Chemistry. Unidades: FCF, ICB, PRÓ-G
Assuntos: CITOTOXICIDADE IMUNOLÓGICA, ENZIMAS, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Maurício Temotheo et al. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, v. 35, p. 1-42 art. 116085, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2021.116085. Acesso em: 24 jun. 2024.
APA
Tavares, M. T., Almeida, L. C. de, Kronenberger, T., Ferreira, G. M., Divitiis, T. F. de, Toledo, M. F. Z. J., et al. (2021). Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors. Bioorganic and Medicinal Chemistry, 35, 1-42 art. 116085. doi:10.1016/j.bmc.2021.116085
NLM
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Lotufo LVC, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Vancouver
Tavares MT, Almeida LC de, Kronenberger T, Ferreira GM, Divitiis TF de, Toledo MFZJ, Hassimotto NMA, Machado Neto JA, Lotufo LVC, Parise Filho R. Structure-activity relationship and mechanistic studies for a series of cinnamyl hydroxamate histone deacetylase inhibitors [Internet]. Bioorganic and Medicinal Chemistry. 2021 ; 35 1-42 art. 116085.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.bmc.2021.116085
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Fonte: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Assuntos: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 24 jun. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
Targeting SUMOylation in plasmodium as a potential target for malaria therapy (2021)
Oliveira, Daffiny Sumam de ; Kronenberger, Thales ; Palmisano, Giuseppe ; Wrenger, Carsten ; Souza, Edmarcia Elisa de
Fonte: Frontiers in Cellular and Infection Microbiology. Unidade: ICB
Assuntos: PARASITOLOGIA, MALÁRIA, PLASMODIUM FALCIPARUM, ANTIMALÁRICOS, ANIMAIS PARASITOS, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Daffiny Sumam de et al. Targeting SUMOylation in plasmodium as a potential target for malaria therapy. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-7, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.685866. Acesso em: 24 jun. 2024.
APA
Oliveira, D. S. de, Kronenberger, T., Palmisano, G., Wrenger, C., & Souza, E. E. de. (2021). Targeting SUMOylation in plasmodium as a potential target for malaria therapy. Frontiers in Cellular and Infection Microbiology, 11, 1-7. doi:10.3389/fcimb.2021.685866
NLM
Oliveira DS de, Kronenberger T, Palmisano G, Wrenger C, Souza EE de. Targeting SUMOylation in plasmodium as a potential target for malaria therapy [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-7.[citado 2024 jun. 24 ] Available from: https://doi.org/10.3389/fcimb.2021.685866
Vancouver
Oliveira DS de, Kronenberger T, Palmisano G, Wrenger C, Souza EE de. Targeting SUMOylation in plasmodium as a potential target for malaria therapy [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-7.[citado 2024 jun. 24 ] Available from: https://doi.org/10.3389/fcimb.2021.685866
Artigo de periodico
Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2 (2020)
Bosch, Soraya Soledad ; Lunev, Sergey ; Batista, Fernando de Assis ; Linzke, Marleen; Kronenberger, Thales ; Dömling, Alexander S. S. ; Groves, Matthew R. ; Wrenger, Carsten
Fonte: ACS Infectious Diseases. Unidade: ICB
Assuntos: PARASITOLOGIA, COMPOSTOS ORGÂNICOS, PLASMODIUM FALCIPARUM, ASPARTATO CARBAMOILTRANSFERASE, ANIMAIS PARASITOS, MUTAÇÃO, ANTIMALÁRICOS, ATIVAÇÃO ENZIMÁTICA, MALÁRIA, ANIMAIS PARASITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOSCH, Soraya Soledad et al. Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2. ACS Infectious Diseases, v. 6. n. 5, p. 986-999, 2020Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.9b00411. Acesso em: 24 jun. 2024.
APA
Bosch, S. S., Lunev, S., Batista, F. de A., Linzke, M., Kronenberger, T., Dömling, A. S. S., et al. (2020). Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2. ACS Infectious Diseases, 6. n. 5, 986-999. doi:10.1021/acsinfecdis.9b00411
NLM
Bosch SS, Lunev S, Batista F de A, Linzke M, Kronenberger T, Dömling ASS, Groves MR, Wrenger C. Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2 [Internet]. ACS Infectious Diseases. 2020 ; 6. n. 5 986-999.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1021/acsinfecdis.9b00411
Vancouver
Bosch SS, Lunev S, Batista F de A, Linzke M, Kronenberger T, Dömling ASS, Groves MR, Wrenger C. Molecular target validation of aspartate transcarbamoylase from Plasmodium falciparum by torin 2 [Internet]. ACS Infectious Diseases. 2020 ; 6. n. 5 986-999.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1021/acsinfecdis.9b00411
Artigo de periodico
QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives (2020)
Ferreira, Glaucio Monteiro; Magalhães, Juliana Gallottini de; Maltarollo, Vinícius Gonçalves; Kronenberger, Thales; Ganesan, Arasu; Emery, Flavio da Silva; Trossini, Gustavo Henrique Goulart
Fonte: Journal of Biomolecular Structure and Dynamics. Unidades: FCFRP, FCF
Assuntos: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, v. 38, n. 2, p. 354-363, 2020Tradução . . Disponível em: https://doi.org/10.1080/07391102.2019.1574603. Acesso em: 24 jun. 2024.
APA
Ferreira, G. M., Magalhães, J. G. de, Maltarollo, V. G., Kronenberger, T., Ganesan, A., Emery, F. da S., & Trossini, G. H. G. (2020). QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives. Journal of Biomolecular Structure and Dynamics, 38( 2), 354-363. doi:10.1080/07391102.2019.1574603
NLM
Ferreira GM, Magalhães JG de, Maltarollo VG, Kronenberger T, Ganesan A, Emery F da S, Trossini GHG. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives [Internet]. Journal of Biomolecular Structure and Dynamics. 2020 ; 38( 2): 354-363.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1080/07391102.2019.1574603
Vancouver
Ferreira GM, Magalhães JG de, Maltarollo VG, Kronenberger T, Ganesan A, Emery F da S, Trossini GHG. QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives [Internet]. Journal of Biomolecular Structure and Dynamics. 2020 ; 38( 2): 354-363.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1080/07391102.2019.1574603
Artigo de periodico
Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors (2020)
Kronenberger, Thales ; Ferreira, Glaucio Monteiro ; Souza, Alfredo Danilo Ferreira de ; Santos, Soraya da Silva; Poso, Antti ; Ribeiro, João Augusto; Tavares, Maurício Temotheo ; Pavan, Fernando Rogério ; Trossini, Gustavo Henrique Goulart ; Dias, Marcio Vinicius Bertacine ; Parise Filho, Roberto
Fonte: Bioorganic & Medicinal Chemistry. Unidades: FCF, ICB
Assuntos: MICROBIOLOGIA, METABÓLITOS, ÁCIDOS CARBOXÍLICOS, DNA, TUBERCULOSE, CINÉTICA QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KRONENBERGER, Thales et al. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, v. 28, n. 15, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115600. Acesso em: 24 jun. 2024.
APA
Kronenberger, T., Ferreira, G. M., Souza, A. D. F. de, Santos, S. da S., Poso, A., Ribeiro, J. A., et al. (2020). Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, 28( 15), 10 . doi:10.1016/j.bmc.2020.115600
NLM
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Vancouver
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2024 jun. 24 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600
Trabalho de evento-resumo
Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling (2019)
Ferreira, Glaucio Monteiro ; Oliveira, Victor Fernandes de ; Kronenberger, Thales ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Feres, Fausto
Fonte: Proceedings. Nome do evento: International Conference of the Brazilian Association of Bioinformatics and Computational Biology/AB3C. Unidade: FCF
Assuntos: MODELAGEM MOLECULAR, DISLIPIDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. 2019, Anais.. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C, 2019. . Acesso em: 24 jun. 2024.
APA
Ferreira, G. M., Oliveira, V. F. de, Kronenberger, T., Hirata, R. D. C., Hirata, M. H., & Feres, F. (2019). Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. In Proceedings. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C.
NLM
Ferreira GM, Oliveira VF de, Kronenberger T, Hirata RDC, Hirata MH, Feres F. Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. Proceedings. 2019 ;[citado 2024 jun. 24 ]
Vancouver
Ferreira GM, Oliveira VF de, Kronenberger T, Hirata RDC, Hirata MH, Feres F. Novel HMG-CoA reductase inhibitors development by integrating dyslipidemic patients genetic studies and molecular modelling. Proceedings. 2019 ;[citado 2024 jun. 24 ]
Trabalho de evento-resumo
PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions (2019)
Lopes, Vitor Galvão ; Oliveira, Victor Fernandes de ; Kronenberger, Thales ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Ferreira, Glaucio Monteiro
Fonte: Proceedings. Nome do evento: International Conference of the Brazilian Association of Bioinformatics and Computational Biology/AB3C. Unidade: FCF
Assuntos: DISLIPIDEMIAS, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Vitor Galvão et al. PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. 2019, Anais.. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C, 2019. . Acesso em: 24 jun. 2024.
APA
Lopes, V. G., Oliveira, V. F. de, Kronenberger, T., Hirata, M. H., Hirata, R. D. C., & Ferreira, G. M. (2019). PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. In Proceedings. Campos do Jordão: Associação Brasileira de Bioinformática e Biologia Computacional/AB3C.
NLM
Lopes VG, Oliveira VF de, Kronenberger T, Hirata MH, Hirata RDC, Ferreira GM. PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. Proceedings. 2019 ;[citado 2024 jun. 24 ]
Vancouver
Lopes VG, Oliveira VF de, Kronenberger T, Hirata MH, Hirata RDC, Ferreira GM. PCSK9 three-dimensional reconstruction by homology modelling and new LDL receptor interaction regions. Proceedings. 2019 ;[citado 2024 jun. 24 ]
Artigo de periodico
Advances with support vector machines for novel drug discovery (2019)
Maltarollo, Vinicius Gonçalves; Kronenberger, Thales; Espinoza, Gabriel Zarzana; Oliveira, Patricia Rufino; Honorio, Kathia Maria
Fonte: Expert Opinion on Drug Discovery. Unidade: EACH
Assuntos: QUÍMICA MÉDICA, PLANEJAMENTO DE FÁRMACOS, RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALTAROLLO, Vinicius Gonçalves et al. Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, v. 14, n. Ja 2019, p. 01-11, 2019Tradução . . Disponível em: https://doi.org/10.1080/17460441.2019.1549033. Acesso em: 24 jun. 2024.
APA
Maltarollo, V. G., Kronenberger, T., Espinoza, G. Z., Oliveira, P. R., & Honorio, K. M. (2019). Advances with support vector machines for novel drug discovery. Expert Opinion on Drug Discovery, 14( Ja 2019), 01-11. doi:10.1080/17460441.2019.1549033
NLM
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Vancouver
Maltarollo VG, Kronenberger T, Espinoza GZ, Oliveira PR, Honorio KM. Advances with support vector machines for novel drug discovery [Internet]. Expert Opinion on Drug Discovery. 2019 ; 14( Ja 2019): 01-11.[citado 2024 jun. 24 ] Available from: https://doi.org/10.1080/17460441.2019.1549033
Artigo de periodico
The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation (2019)
Gao, kai ; Wang, ; Kronenberger, Thales ; Wrenger, Carsten ; Groves, Matthew
Fonte: Crystals. Unidade: ICB
Assuntos: PARASITOLOGIA, PLASMODIUM FALCIPARUM, MALÁRIA, ANTIMALÁRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GAO, kai et al. The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation. Crystals, v. 9, n. 10, p. 1-11, 2019Tradução . . Disponível em: https://doi.org/10.3390/cryst9100534. Acesso em: 24 jun. 2024.
APA
Gao, kai, Wang,, Kronenberger, T., Wrenger, C., & Groves, M. (2019). The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation. Crystals, 9( 10), 1-11. doi:10.3390/cryst9100534
NLM
Gao kai, Wang, Kronenberger T, Wrenger C, Groves M. The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation [Internet]. Crystals. 2019 ; 9( 10): 1-11.[citado 2024 jun. 24 ] Available from: https://doi.org/10.3390/cryst9100534
Vancouver
Gao kai, Wang, Kronenberger T, Wrenger C, Groves M. The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation [Internet]. Crystals. 2019 ; 9( 10): 1-11.[citado 2024 jun. 24 ] Available from: https://doi.org/10.3390/cryst9100534

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos